Results 11 to 20 of about 10,864 (278)

Effect of brimonidine tartrate on basophil activation in glaucoma patients

International Journal of Ophthalmology, 2020
AIM: To evaluate the mechanism of which brimonidine tartrate 0.15% causes clinical hypersensitivity. METHODS: A prospective case-control study comparing 8 glaucoma patients with clinical hypersensitivity to brimonidine to a control group consisting 13 ...
Eldar Rosenfeld, Dana Barequet, Gilad Rabina, Sheila Langier, Moshe Lazar, Gabi Shemesh, Shimon Kurtz, Shmuel Kivity   +7 more
doaj   +2 more sources

Exploring Neuroprotective Effects of Topical Brimonidine in Experimental Diabetic Retinopathy. [PDF]

In Vivo
Background/Aim: Diabetic retinopathy is a leading cause of blindness worldwide, characterized by neurovascular dysfunction. This study aimed to investigate the impact of brimonidine, a selective adrenoceptor agonist, on diabetic retinal neurodegeneration,
Jung KI, Kim JH, Han JS, Park CK.
europepmc   +2 more sources

Efficacy of three different formulations of brimonidine for control of intraocular pressure in primary open-angle glaucoma: A 6-week randomized trial

Oman Journal of Ophthalmology, 2018
BACKGROUND: To compare the intraocular pressure (IOP)-lowering efficacy and safety of brimonidine (0.2%), brimonidine purite (0.15%), and brimonidine purite (0.1%) in patients of primary open-angle glaucoma (POAG).
Anubha Bhatti, Gursatinder Singh
doaj   +2 more sources

Symptomatic bradycardia associated with topical brimonidine gel (Mirvaso) administration: a case report. [PDF]

Eur Heart J Case Rep
Background Bradycardia can have a number of different aetiologies, including as a side effect of medications. Brimonidine is a rare, but recognized, cause of bradycardia.
Jesudason DI, Appalanaidu N, Khan A.
europepmc   +2 more sources

Visual field testing and glaucoma drug prescribing patterns in Australia. [PDF]

Ophthalmic Physiol Opt
Abstract Purpose To examine glaucoma practice patterns in Australia, focusing on visual field test uptake and antiglaucoma drug prescribing by optometrists and ophthalmologists. Design A serial cross‐sectional study was conducted to describe visual field testing charges and compare them to changes in comprehensive eye examination charges, as well as to
Jan CL, Vingrys A, Stafford RS, Kang M, Shang X, Hu W, Liu J, Joseph S, He M.   +8 more
europepmc   +2 more sources

The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients

Clinical Ophthalmology, 2014
Toyoaki Tsumura,1 Keiji Yoshikawa,2 Tairo Kimura,3 Hirotaka Suzumura,4 Miwako Kawashima,5 Mami Nanno,6 Kiyotaka Ishijima,7 Ryuji Takeda8 1Fussa Hospital, Tokyo, Japan; 2Yoshikawa Eye Clinic, Tokyo, Japan; 3Ueno Eye Clinic, Tokyo, Japan; 4Suzumura Eye ...
Tsumura T, Yoshikawa K, Kimura T, Suzumura H, Kawashima M, Nanno M, Ishijima K, Takeda R   +7 more
doaj   +3 more sources

Brimonidine-Soluplus Nanomicelles: Preparation and in-vitro evaluation

Iraqi Journal of Pharmaceutical Sciences
Brimonidine is an active pharmaceutical ingredient used to treat glaucoma as a topical eye drop. Ophthalmic topical preparations are associated with low ocular bioavailability due to several physiological and analytical barriers.
Noor Al wiswasi, Fatima J. Al-Gawahri
doaj   +2 more sources

Brimonidine Eye Drops within the Reach of Children: A Possible Foe

Children
Brimonidine, a selective alpha-2 adrenergic agonist used for the treatment of open-angle glaucoma, has been shown to cause neurological side effects such as unresponsiveness, lethargy, hypoventilation, and stupor, mimicking opioid toxicity. We report one
Daniela Trotta, Mirco Zucchelli, Carmela Salladini, Patrizia Ballerini, Claudia Rossi, Maurizio Aricò   +5 more
doaj   +2 more sources

Brimonidine-associated uveitis – a descriptive case series [PDF]

BMC Ophthalmology, 2020
Background Anterior uveitis secondary to topical brimonidine administration is rare and not well-defined. In glaucoma patients using brimonidine, one must consider this phenomenon to avoid mis-diagnosis and over-treatment with topical steroids which in ...
Susanne Hopf, Karl Mercieca, Norbert Pfeiffer, Verena Prokosch-Willing   +3 more
doaj   +6 more sources

Novel Uses of Brimonidine

Delhi Journal of Ophthalmology
Brimonidine tartrate is a third-generation, highly selective alpha 2 agonist currently available in various formulations and doses to treat ophthalmological conditions. The aim of this article was to review pharmacokinetics, mechanisms, side effects, and
Hikkalagutti. S. Kruthika, Chauhan Tulika, Patyal Sagarika, Bhardwaj Kanika, Dabas Garvita   +4 more
doaj   +2 more sources